LPS induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4

Digestive Diseases and Sciences

Volumn 59, Issue 7, 2014, Pages 1452-1460

  Liu, Jianhui ^a   Xu, Dong ^b   Wang, Qingguang ^a   Zheng, Datong ^a   Jiang, Xiuqin ^a   Xu, Lijian ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Gaochun People's Hospital   (China)

Author keywords

MAP2K4; MiR 181a; Pancreatic cancer; PTEN; TLR4

Indexed keywords

LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 181A; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER TISSUE; CELL MIGRATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; INFLAMMATION; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICRORNAS; PANCREATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR MARKERS, BIOLOGICAL;

EID: 84903536770     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3049-y     Document Type: Article

References (34)

1. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009;6:699-708.
2. Barkin JS, Goldstein JA. Diagnostic and therapeutic approach to pancreatic cancer. Biomed Pharmacother. 2000;54:400-409.
3. Mantovani A. CANCER inflaming metastasis. Nature. 2009;457: 36-37.
4. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436-444.
5. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30:1073-1081.
6. Wen F, Shen A, Choi A, Gerner EW, Shi J. Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis. Cancer Res. 2013;73(14):4256-4266. doi:10.1158/0008-5472.
7. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell . 2006;124:783-801. (Pubitemid 43261452)
8. O'Neill LA. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol. 2006;18:3-9. (Pubitemid 43049641)
9. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol. 2004;5:975-979. (Pubitemid 41057713)
10. Goto Y, Arigami T, Kitago M, Nguyen SL, et al. Activation of Tolllike receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther. 2008;7:3642-3653.
11. Kelly MG, Alvero AB, Chen R, Silasi DA, et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 2006;66:3859-3868.
12. Jurk M, Vollmer J. Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation. BioDrugs . 2007;21:387-401. (Pubitemid 350145447)
13. West AP, Koblansky AA, Ghosh S. Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol. 2006;22:409-437.
14. Triantafilou K, Triantafilou M, Dedrick RL. A CD14-independent LPS receptor cluster. Nat Immunol. 2001;4:338-345.
15. Suzanne LT, Kevin JZ, Seth BC, Ruth SW, Elizabeth SD, Aline BS. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells. 2008;26:99-107.
16. Ikebe M, Kitaura Y, Nakamura M, Tanaka H, et al. Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway. J Surg Oncol. 2009;100:725-731.
17. Nicoloso MS, Calin GA. MicroRNA involvement in brain tumors: from bench to bedside. Brain Pathol. 2008;18:122-129.
18. Wang HW, Mendell JT. MicroRNAs in cell proliferation, cell death and tumorigenesis. Br J Cancer. 2006;94:776-780.
19. Hulsmans M, Sinnaeve P, Van der Schueren B, Mathieu C, Janssens S, Holvoet P. Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery disease. J Clin Endocrinol Metab. 2012;97:E1213-E1218.
20. Bloomston M, Frankel WL, Petrocca F. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297:1901-1908. (Pubitemid 46707844)
21. Zhang Y, Li M, Wang H. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg. 2009;33:698-709.
22. Xie W, Li Z, Li M, Xu N, Zhang Y. miR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo. Biochem Biophys Res Commun. 2013;430:647-652.
23. Luo H, Yang Y, Duan J, Wu P, Jiang Q, Xu C. PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells. Cell Death Dis. 2013;7:e481.
24. Yamada KM, Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci. 2001;114:2375-2382. (Pubitemid 32684793)
25. Xin W, Yun KJ, Ricci F, Zahurak M, et al. MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course. Clin Cancer Res. 2004;10:8516-8520. (Pubitemid 40053418)
26. Ishikawa M, Nakayama K, Rahman MT, Rahman M, et al. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer. Oncology. 2010;79:238-246.
27. Michaud DS, Izard J,Wilhelm-Benartzi CS, You DH, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut. 2013;62:1764-1770.
28. Michaud DS. Role of bacterial infections in pancreatic cancer. Carcinogenesis. 2013;34:2193-2197.
29. Price JC, Bromfield JJ, Sheldon IM. Pathogen-associated molecular patterns initiate inflammation and perturb the endocrine function of bovine granulosa cells from ovarian dominant follicles via TLR2 and TLR4 pathways. Endocrinology. 2013; 154(9):3377-3386.
30. Zhang JJ, Wu HS, Wang L, Tian Y, Zhang JH, Wu HL. Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma. World J Gastroenterol. 2010;16: 2881-2888.
31. Del Pozo JL. Primers on molecular pathways: lipopolysaccharide signaling-potential role in pancreatitis and pancreatic cancer. Pancreatology. 2010;10:114-118.
32. Jianwei Z, Fan L, Xiancheng L, Enzhong B, Shuai L, Can L. MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell. Tumour Biol. 2013;34: 3331-3337.
33. Taylor MA, Sossey-Alaoui K, Thompson CL, Danielpour D, Schiemann WP. TGF-β upregulates miR-181a expression to promote breast cancer metastasis. J Clin Invest. 2013;123: 150-163.
34. Chu EC, Tarnawski AS. PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit. 2004;10: RA235-RA2341.